P-273. Risk Factors for 90-day Mortality Among Patients With Stenotrophomonas maltophilia Infection: A Retrospective Multicenter study
Abstract
Abstract Background Stenotrophomonas maltophilia is a leading cause of mortality in critically ill and immunocompromised patients. This study aimed to characterize risk factors for mortality and evaluate if combination therapy or resistance patterns affect mortality in patients with S. maltophilia infections. Methods We conducted a retrospective, observational study at two academic medical centers in the United States including patients aged ≥ 18 years with positive S. maltophilia cultures between January 2019 and March 2024. Logistic regression analysis was performed to identify independent risk factors for 90-day mortality. A sub analysis for patients with pneumonia was performed. Standard of care was defined as monotherapy with trimethoprim-sulfamethoxazole (SXT) or levofloxacin. Results A total of 128 patients were included, median age was 66 years; 60.9% were male. 30- and 90-day mortality rates were 17.2% and 25%, respectively. The most common source of infection was pneumonia (52, 40.6%), which also had the highest mortality rates (32.7%, 46.2%) when compared to other sources of infection. Although non-survivors had higher rates of COPD (p=0.04), prior organ transplants (p=0.002), prior steroid use (p=0.03), and higher ICU admission rates (p< 0.001), they were not found to be independent risk factors for mortality. Risk factors for 90-day mortality include neutropenia (OR 12.237, p=0.047), polymicrobial infection (OR 7.93, p=0.009) and previous carbapenem use (OR…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.